EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study

Konstantinos Porpodis, Nikolaos Zias, Konstantinos Kostikas, Argyris Tzouvelekis, Michael Makris, George N Konstantinou iD, Eleftherios Zervas, Stelios Loukides, Paschalis Steiropoulos, Konstantinos Katsoulis, Anastasios Palamidas, Aikaterini Syrigou und 23 weitere

Clinical and Translational Allergy · 2025-02 · 15 (2)

DOI: 10.1002/clt2.70035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Allergy, online erschienen am 29.01.2025. Verfasst von Konstantinos Porpodis und 34 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Department, Aristotle University of Thessaloniki, G. Papanikolaou Hospital, Thessaloniki, Greece. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca S.A. Greece.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data on type 2 (T2)‐low severe asthma (SA) frequency is scarce, resulting in an undefined unmet therapeutic need in this patient population. Our objective was to assess the frequency and characterize the profile and burden of T2‐low SA in Greece.

Methods

PHOLLOW was a cross‐sectional study of adult SA patients. Based on a novel proposed classification system, patients were classified as T2‐low if blood eosinophil count (BEC; cells/μL) was

Schlagwörter

Stichwörter der Autor:innen

clinically significant exacerbationsquality of lifereal‐worldsymptom controltreatment patterns

Autor:innen und Institutionen

  • Pulmonary Department, Aristotle University of Thessaloniki, G. Papanikolaou Hospital, Thessaloniki, Greece.
  • Respiratory Department, Navy Hospital of Athens, Athens, Greece.
  • Respiratory Medicine Department, School of Medicine, University of Ioannina, Ioannina, Greece.
  • Department of Respiratory Medicine, Medical School, University of Patras, Patras, Greece.
  • 2nd Department of Dermatology and Venereology, Allergy Unit, Medical School, Attikon University General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Allergy and Clinical Immunology, 424 General Military Training Hospital, Thessaloniki, Greece.

ORCID-Profile: George N Konstantinou, Petros Bakakos

Förderung

  • AstraZeneca S.A. Greece

Zitieren

APA

Porpodis, K., Zias, N., Kostikas, K., Tzouvelekis, A., Makris, M., Konstantinou, G. N., Zervas, E., Loukides, S., Steiropoulos, P., Katsoulis, K., Palamidas, A., Syrigou, A., Gangadi, M., Christopoulos, A., Papapetrou, D., Psarros, F., Gourgoulianis, K., Tzortzaki, E., Vittorakis, S. K., …, & Bakakos, P. (2025). T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study. Clinical and Translational Allergy, 15(2). https://doi.org/10.1002/clt2.70035

Vancouver

Porpodis K, Zias N, Kostikas K, Tzouvelekis A, Makris M, Konstantinou GN, et al. T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study. Clinical and Translational Allergy. 2025;15(2). doi:10.1002/clt2.70035

BibTeX
@article{Porpodis2025,
  author = {Porpodis, Konstantinos and Zias, Nikolaos and Kostikas, Konstantinos and Tzouvelekis, Argyris and Makris, Michael and Konstantinou, George N and Zervas, Eleftherios and Loukides, Stelios and Steiropoulos, Paschalis and Katsoulis, Konstantinos and Palamidas, Anastasios and Syrigou, Aikaterini and Gangadi, Maria and Christopoulos, Antonios and Papapetrou, Dimosthenis and Psarros, Fotios and Gourgoulianis, Konstantinos and Tzortzaki, Eleni and Vittorakis, Stylianos K and Paraskevopoulos, Ioannis and Papanikolaou, Ilias and Krommidas, Georgios and Latsios, Dimitrios and Tzanakis, Nikolaos and Markatos, Miltiadis and Damianaki, Angeliki and Manikas, Argyrios and Chatzipetrou, Alexia and Vourdas, Dimitrios and Tsiouprou, Ioanna and Papista, Christina and Bartsakoulia, Marina and Mathioudakis, Nikolas and Galanakis, Petros and Bakakos, Petros},
  title = {T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study},
  journal = {Clinical and Translational Allergy},
  year = {2025},
  volume = {15},
  number = {2},
  doi = {10.1002/clt2.70035}
}
Kostenlos starten →